๐ŸŽ Black Friday: up to 50% off of annual plans
Arrowhead Pharmaceuticals, Inc. (ARWR)
NASDAQ: ARWR ยท Real-Time Price ยท USD
41.37
-2.28 (-5.22%)
At close: Nov 20, 2026, 4:00 PM EST
41.40
+0.03 (0.07%)
After-hours: Nov 20, 2026, 7:30 PM EST

Arrowhead Pharmaceuticals Financials Overview

Millions USD. Fiscal year is Oct - Sep.

Revenue & Profits

Fiscal Year
TTMFY 2026FY 2025FY 2024FY 2023FY 2022
Period EndingSep '26 Sep '26 Sep '25 Sep '24 Sep '23 Sep '22
Revenue
450.82450.82829.453.55240.74243.23
Revenue Growth
-45.65%-45.65%23258.15%-98.52%-1.03%75.89%
Gross Profit
449.02449.02829.453.55240.74243.23
Operating Income
-707.17-707.1798.35-601.08-205-178.51
Net Income
-724.21-724.21-1.63-599.49-205.28-176.06
Earnings Per Share
-5.11-5.11-0.01-5.00-1.92-1.67
EPS Growth
------

Revenue by Segment

Fiscal Year
TTMFY 2026FY 2025FY 2024FY 2023FY 2022
Period EndingSep '26 Sep '26 Sep '25 Sep '24 Sep '23 Sep '22
Product
6.66.6----
GSK
--2.652.6929.66124.76
Sarepta
316.89316.89696.8---
Novartis
89.0189.01----
Sanofi
13.3213.32130---
Madrigal
2525----
Revenue (Total)
450.82450.82829.453.55240.74243.23

Cash & Debt

Fiscal Year
CurrentFY 2026FY 2025FY 2024FY 2023FY 2022
Period EndingSep '26 Sep '26 Sep '25 Sep '24 Sep '23 Sep '22
Cash & Investments
1,1891,189917.47677.46395.73369.1
Total Debt
1,4071,407733.68851.91383.581.58
Net Cash (Debt)
-218.59-218.59183.79-174.4512.23287.52
Net Cash Growth
-----95.75%-15.99%
Net Cash Per Share
-1.54-1.541.37-1.460.112.73

Cash Flow & CapEx

Fiscal Year
TTMFY 2026FY 2025FY 2024FY 2023FY 2022
Period EndingSep '26 Sep '26 Sep '25 Sep '24 Sep '23 Sep '22
Operating Cash Flow
-271.95-271.95179.55-462.85-153.89-136.13
Capital Expenditures
-12-12-22.67-141.47-176.74-52.78
Free Cash Flow
-283.94-283.94156.89-604.32-330.63-188.91
Free Cash Flow Growth
------

Margins

Fiscal Year
TTMFY 2026FY 2025FY 2024FY 2023FY 2022
Period EndingSep '26 Sep '26 Sep '25 Sep '24 Sep '23 Sep '22
Gross Margin
99.60%99.60%100.00%100.00%100.00%100.00%
Operating Margin
-156.86%-156.86%11.86%-16927.06%-85.16%-73.39%
Pretax Margin
-160.58%-160.58%6.21%-17247.54%-85.78%-71.01%
Profit Margin
-160.64%-160.64%-0.20%-16882.37%-85.27%-72.39%
FCF Margin
-62.98%-62.98%18.92%-17018.31%-137.34%-77.67%

Valuation

Fiscal Year
CurrentFY 2026FY 2025FY 2024FY 2023FY 2022
Period EndingNov '26 Sep '26 Sep '25 Sep '24 Sep '23 Sep '22
Forward PE
-140.94140.94140.94140.94140.94
P/FCF Ratio
--30.40---
PS Ratio
12.9720.515.75678.1211.9614.38